Article
Induction of mutant lymphocytes in cyclophosphamide- and chlorambucil-treated patients.
Mutagenesis - 1 May 2001
Sanderson B J, Johnson K J, Henner W D
Abstract excerpt
Monitoring patients treated with single antineoplastic agents is aiding our understanding of what hazard these drugs pose in vivo. In this study, the frequency of mutant 6-thioguanine-resistant (TG(R)) peripheral blood lymphocytes was monitored before treatment and for < or =35 weeks after treatment of patients with cyclophosphamide (CP) or chlorambucil (CAB). The mean mutant frequency before treatment for six...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
